Natco Pharma receives EDQM certifications

Hyderabad-based Natco Pharma Limited has received the certification of suitability of monographs of the European Pharmacopoeia for its active pharmaceutical ingredients "� Ondansetron Hyderochloride Dihydrate and Sumatrptan Succinate.

These certifications are granted by the European Directorate for the Quality of Medicines (EDQM) after a thorough evaluation of the drug master files filed by the company. Customers in the European countries can now procure these products from Natco.

These companies can then convert these bulk products into finished dosage formulations for sales in the European Union. The launch of these formulations is slated in early this year while the API shipments are expected to take place within the quarter ending March 31.

Ondansetron Hydrochloride Dihydrate is a drug for suppressing emetic tendencies among cancer patients under medication.